nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00641	0.174	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Dexamethasone—psoriatic arthritis	0.00631	0.172	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Betamethasone—psoriatic arthritis	0.00631	0.172	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Triamcinolone—psoriatic arthritis	0.00617	0.168	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Prednisone—psoriatic arthritis	0.00585	0.159	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Prednisolone—psoriatic arthritis	0.00571	0.155	CbGdCrCtD
Melphalan—Neuropathy—Prednisolone—psoriatic arthritis	0.00475	0.00493	CcSEcCtD
Melphalan—Bone marrow depression—Methotrexate—psoriatic arthritis	0.00455	0.00473	CcSEcCtD
Melphalan—Liver disorder—Methotrexate—psoriatic arthritis	0.00451	0.00468	CcSEcCtD
Melphalan—Urticaria—Auranofin—psoriatic arthritis	0.0045	0.00467	CcSEcCtD
Melphalan—Ulcer—Dexamethasone—psoriatic arthritis	0.00447	0.00464	CcSEcCtD
Melphalan—Ulcer—Betamethasone—psoriatic arthritis	0.00447	0.00464	CcSEcCtD
Melphalan—Skin exfoliation—Triamcinolone—psoriatic arthritis	0.00444	0.00461	CcSEcCtD
Melphalan—Skin exfoliation—Methylprednisolone—psoriatic arthritis	0.00443	0.0046	CcSEcCtD
Melphalan—Neuropathy—Triamcinolone—psoriatic arthritis	0.00437	0.00454	CcSEcCtD
Melphalan—Neuropathy—Methylprednisolone—psoriatic arthritis	0.00436	0.00453	CcSEcCtD
Melphalan—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.00434	0.00451	CcSEcCtD
Melphalan—Vasculitis—Betamethasone—psoriatic arthritis	0.00433	0.00449	CcSEcCtD
Melphalan—Vasculitis—Dexamethasone—psoriatic arthritis	0.00433	0.00449	CcSEcCtD
Melphalan—Amenorrhoea—Prednisone—psoriatic arthritis	0.00419	0.00435	CcSEcCtD
Melphalan—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.00403	0.00419	CcSEcCtD
Melphalan—Skin exfoliation—Betamethasone—psoriatic arthritis	0.00403	0.00419	CcSEcCtD
Melphalan—Pruritus—Auranofin—psoriatic arthritis	0.00401	0.00416	CcSEcCtD
Melphalan—Neuropathy—Betamethasone—psoriatic arthritis	0.00397	0.00412	CcSEcCtD
Melphalan—Neuropathy—Dexamethasone—psoriatic arthritis	0.00397	0.00412	CcSEcCtD
Melphalan—Skin ulcer—Methotrexate—psoriatic arthritis	0.00395	0.0041	CcSEcCtD
Melphalan—Ulcer—Prednisone—psoriatic arthritis	0.00389	0.00404	CcSEcCtD
Melphalan—Diarrhoea—Auranofin—psoriatic arthritis	0.00388	0.00402	CcSEcCtD
Melphalan—Vasculitis—Prednisone—psoriatic arthritis	0.00377	0.00391	CcSEcCtD
Melphalan—Vomiting—Auranofin—psoriatic arthritis	0.0036	0.00374	CcSEcCtD
Melphalan—Rash—Auranofin—psoriatic arthritis	0.00357	0.00371	CcSEcCtD
Melphalan—Dermatitis—Auranofin—psoriatic arthritis	0.00357	0.0037	CcSEcCtD
Melphalan—Extravasation—Methotrexate—psoriatic arthritis	0.00352	0.00366	CcSEcCtD
Melphalan—Skin exfoliation—Prednisone—psoriatic arthritis	0.00351	0.00365	CcSEcCtD
Melphalan—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00349	0.00363	CcSEcCtD
Melphalan—Neuropathy—Prednisone—psoriatic arthritis	0.00345	0.00359	CcSEcCtD
Melphalan—Nausea—Auranofin—psoriatic arthritis	0.00336	0.00349	CcSEcCtD
Melphalan—Hyperuricaemia—Methotrexate—psoriatic arthritis	0.00331	0.00344	CcSEcCtD
Melphalan—Ulcer—Methotrexate—psoriatic arthritis	0.00325	0.00337	CcSEcCtD
Melphalan—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00321	0.00334	CcSEcCtD
Melphalan—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00321	0.00333	CcSEcCtD
Melphalan—Vasculitis—Methotrexate—psoriatic arthritis	0.00315	0.00327	CcSEcCtD
Melphalan—Blood uric acid increased—Methotrexate—psoriatic arthritis	0.00313	0.00325	CcSEcCtD
Melphalan—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.003	0.00312	CcSEcCtD
Melphalan—Cystitis—Methotrexate—psoriatic arthritis	0.00297	0.00308	CcSEcCtD
Melphalan—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00294	0.00305	CcSEcCtD
Melphalan—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00292	0.00303	CcSEcCtD
Melphalan—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00292	0.00303	CcSEcCtD
Melphalan—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00287	0.00298	CcSEcCtD
Melphalan—Neoplasm—Methotrexate—psoriatic arthritis	0.00278	0.00289	CcSEcCtD
Melphalan—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00278	0.00289	CcSEcCtD
Melphalan—Bladder pain—Methotrexate—psoriatic arthritis	0.00278	0.00289	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00278	0.00288	CcSEcCtD
Melphalan—Haemoglobin—Prednisolone—psoriatic arthritis	0.00256	0.00265	CcSEcCtD
Melphalan—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00255	0.00265	CcSEcCtD
Melphalan—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00255	0.00264	CcSEcCtD
Melphalan—Haemorrhage—Prednisolone—psoriatic arthritis	0.00254	0.00264	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—psoriatic arthritis	0.00254	0.00264	CcSEcCtD
Melphalan—Renal failure acute—Methotrexate—psoriatic arthritis	0.00242	0.00251	CcSEcCtD
Melphalan—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00235	0.00244	CcSEcCtD
Melphalan—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00234	0.00243	CcSEcCtD
Melphalan—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00234	0.00243	CcSEcCtD
Melphalan—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00233	0.00242	CcSEcCtD
Melphalan—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00232	0.0024	CcSEcCtD
Melphalan—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00232	0.0024	CcSEcCtD
Melphalan—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00229	0.00238	CcSEcCtD
Melphalan—Arrhythmia—Prednisolone—psoriatic arthritis	0.00227	0.00236	CcSEcCtD
Melphalan—Neutropenia—Prednisone—psoriatic arthritis	0.00216	0.00224	CcSEcCtD
Melphalan—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00213	0.00221	CcSEcCtD
Melphalan—Haemoglobin—Betamethasone—psoriatic arthritis	0.00213	0.00221	CcSEcCtD
Melphalan—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00212	0.0022	CcSEcCtD
Melphalan—Haemorrhage—Betamethasone—psoriatic arthritis	0.00212	0.0022	CcSEcCtD
Melphalan—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00211	0.00219	CcSEcCtD
Melphalan—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0021	0.00218	CcSEcCtD
Melphalan—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00209	0.00217	CcSEcCtD
Melphalan—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00208	0.00216	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00206	0.00214	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00202	0.00209	CcSEcCtD
Melphalan—Convulsion—Prednisolone—psoriatic arthritis	0.00192	0.00199	CcSEcCtD
Melphalan—Arrhythmia—Dexamethasone—psoriatic arthritis	0.0019	0.00197	CcSEcCtD
Melphalan—Arrhythmia—Betamethasone—psoriatic arthritis	0.0019	0.00197	CcSEcCtD
Melphalan—Alopecia—Betamethasone—psoriatic arthritis	0.00187	0.00195	CcSEcCtD
Melphalan—Alopecia—Dexamethasone—psoriatic arthritis	0.00187	0.00195	CcSEcCtD
Melphalan—Haemoglobin—Prednisone—psoriatic arthritis	0.00186	0.00193	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—psoriatic arthritis	0.00185	0.00192	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—psoriatic arthritis	0.00183	0.0019	CcSEcCtD
Melphalan—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00182	0.00188	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00181	0.00188	CcSEcCtD
Melphalan—Oedema—Prednisolone—psoriatic arthritis	0.00181	0.00188	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—psoriatic arthritis	0.0018	0.00187	CcSEcCtD
Melphalan—Cough—Triamcinolone—psoriatic arthritis	0.00178	0.00184	CcSEcCtD
Melphalan—Convulsion—Triamcinolone—psoriatic arthritis	0.00176	0.00183	CcSEcCtD
Melphalan—Tachycardia—Prednisolone—psoriatic arthritis	0.00176	0.00183	CcSEcCtD
Melphalan—Convulsion—Methylprednisolone—psoriatic arthritis	0.00176	0.00183	CcSEcCtD
Melphalan—Myalgia—Triamcinolone—psoriatic arthritis	0.00173	0.0018	CcSEcCtD
Melphalan—Myalgia—Methylprednisolone—psoriatic arthritis	0.00173	0.00179	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00172	0.00178	CcSEcCtD
Melphalan—Flushing—Prednisone—psoriatic arthritis	0.00171	0.00178	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—psoriatic arthritis	0.00168	0.00174	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—psoriatic arthritis	0.00167	0.00173	CcSEcCtD
Melphalan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00166	0.00172	CcSEcCtD
Melphalan—Oedema—Triamcinolone—psoriatic arthritis	0.00166	0.00172	CcSEcCtD
Melphalan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00166	0.00172	CcSEcCtD
Melphalan—Arrhythmia—Prednisone—psoriatic arthritis	0.00165	0.00171	CcSEcCtD
Melphalan—Infection—Triamcinolone—psoriatic arthritis	0.00165	0.00171	CcSEcCtD
Melphalan—Infection—Methylprednisolone—psoriatic arthritis	0.00165	0.00171	CcSEcCtD
Melphalan—Alopecia—Prednisone—psoriatic arthritis	0.00163	0.00169	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00163	0.00169	CcSEcCtD
Melphalan—Paraesthesia—Prednisolone—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Melphalan—Tachycardia—Triamcinolone—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Melphalan—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Melphalan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00161	0.00167	CcSEcCtD
Melphalan—Convulsion—Dexamethasone—psoriatic arthritis	0.0016	0.00166	CcSEcCtD
Melphalan—Convulsion—Betamethasone—psoriatic arthritis	0.0016	0.00166	CcSEcCtD
Melphalan—Myalgia—Betamethasone—psoriatic arthritis	0.00157	0.00163	CcSEcCtD
Melphalan—Myalgia—Dexamethasone—psoriatic arthritis	0.00157	0.00163	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—psoriatic arthritis	0.00155	0.00161	CcSEcCtD
Melphalan—Hypotension—Methylprednisolone—psoriatic arthritis	0.00155	0.00161	CcSEcCtD
Melphalan—Pain—Prednisolone—psoriatic arthritis	0.00154	0.0016	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—psoriatic arthritis	0.00154	0.0016	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—psoriatic arthritis	0.00154	0.0016	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00152	0.00158	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—psoriatic arthritis	0.00151	0.00157	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00151	0.00157	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00151	0.00157	CcSEcCtD
Melphalan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Melphalan—Oedema—Dexamethasone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Melphalan—Oedema—Betamethasone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Melphalan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Melphalan—Infection—Betamethasone—psoriatic arthritis	0.0015	0.00155	CcSEcCtD
Melphalan—Infection—Dexamethasone—psoriatic arthritis	0.0015	0.00155	CcSEcCtD
Melphalan—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00149	0.00155	CcSEcCtD
Melphalan—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00149	0.00154	CcSEcCtD
Melphalan—Anaemia—Prednisone—psoriatic arthritis	0.00149	0.00154	CcSEcCtD
Melphalan—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00148	0.00154	CcSEcCtD
Melphalan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00148	0.00153	CcSEcCtD
Melphalan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00148	0.00153	CcSEcCtD
Melphalan—Tachycardia—Dexamethasone—psoriatic arthritis	0.00147	0.00153	CcSEcCtD
Melphalan—Tachycardia—Betamethasone—psoriatic arthritis	0.00147	0.00153	CcSEcCtD
Melphalan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00146	0.00152	CcSEcCtD
Melphalan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00146	0.00151	CcSEcCtD
Melphalan—Anorexia—Dexamethasone—psoriatic arthritis	0.00144	0.00149	CcSEcCtD
Melphalan—Anorexia—Betamethasone—psoriatic arthritis	0.00144	0.00149	CcSEcCtD
Melphalan—Urticaria—Prednisolone—psoriatic arthritis	0.00143	0.00149	CcSEcCtD
Melphalan—Fatigue—Triamcinolone—psoriatic arthritis	0.00143	0.00149	CcSEcCtD
Melphalan—Fatigue—Methylprednisolone—psoriatic arthritis	0.00143	0.00148	CcSEcCtD
Melphalan—Pain—Triamcinolone—psoriatic arthritis	0.00142	0.00147	CcSEcCtD
Melphalan—Hypotension—Betamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Melphalan—Hypotension—Dexamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—psoriatic arthritis	0.00139	0.00145	CcSEcCtD
Melphalan—Convulsion—Prednisone—psoriatic arthritis	0.00139	0.00145	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00139	0.00144	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00137	0.00143	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00137	0.00143	CcSEcCtD
Melphalan—Myalgia—Prednisone—psoriatic arthritis	0.00137	0.00142	CcSEcCtD
Melphalan—Alopecia—Methotrexate—psoriatic arthritis	0.00136	0.00142	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00136	0.00141	CcSEcCtD
Melphalan—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00135	0.0014	CcSEcCtD
Melphalan—Paraesthesia—Betamethasone—psoriatic arthritis	0.00135	0.0014	CcSEcCtD
Melphalan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00133	0.00138	CcSEcCtD
Melphalan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00133	0.00138	CcSEcCtD
Melphalan—Dyspepsia—Betamethasone—psoriatic arthritis	0.00133	0.00138	CcSEcCtD
Melphalan—Urticaria—Triamcinolone—psoriatic arthritis	0.00132	0.00137	CcSEcCtD
Melphalan—Urticaria—Methylprednisolone—psoriatic arthritis	0.00132	0.00137	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Melphalan—Oedema—Prednisone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Melphalan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Melphalan—Decreased appetite—Betamethasone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Melphalan—Infection—Prednisone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Melphalan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Melphalan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Melphalan—Fatigue—Dexamethasone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Melphalan—Fatigue—Betamethasone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Melphalan—Pain—Dexamethasone—psoriatic arthritis	0.00129	0.00134	CcSEcCtD
Melphalan—Pain—Betamethasone—psoriatic arthritis	0.00129	0.00134	CcSEcCtD
Melphalan—Tachycardia—Prednisone—psoriatic arthritis	0.00128	0.00133	CcSEcCtD
Melphalan—Skin disorder—Prednisone—psoriatic arthritis	0.00127	0.00132	CcSEcCtD
Melphalan—Anorexia—Prednisone—psoriatic arthritis	0.00125	0.0013	CcSEcCtD
Melphalan—Anaemia—Methotrexate—psoriatic arthritis	0.00124	0.00129	CcSEcCtD
Melphalan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00122	0.00127	CcSEcCtD
Melphalan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00122	0.00127	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—psoriatic arthritis	0.0012	0.00125	CcSEcCtD
Melphalan—Urticaria—Dexamethasone—psoriatic arthritis	0.0012	0.00124	CcSEcCtD
Melphalan—Urticaria—Betamethasone—psoriatic arthritis	0.0012	0.00124	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0012	0.00124	CcSEcCtD
Melphalan—Asthenia—Triamcinolone—psoriatic arthritis	0.00119	0.00124	CcSEcCtD
Melphalan—Asthenia—Methylprednisolone—psoriatic arthritis	0.00119	0.00123	CcSEcCtD
Melphalan—Paraesthesia—Prednisone—psoriatic arthritis	0.00118	0.00122	CcSEcCtD
Melphalan—Pruritus—Triamcinolone—psoriatic arthritis	0.00118	0.00122	CcSEcCtD
Melphalan—Cough—Methotrexate—psoriatic arthritis	0.00117	0.00122	CcSEcCtD
Melphalan—Pruritus—Methylprednisolone—psoriatic arthritis	0.00117	0.00122	CcSEcCtD
Melphalan—Convulsion—Methotrexate—psoriatic arthritis	0.00116	0.00121	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—psoriatic arthritis	0.00116	0.0012	CcSEcCtD
Melphalan—Myalgia—Methotrexate—psoriatic arthritis	0.00114	0.00119	CcSEcCtD
Melphalan—Chest pain—Methotrexate—psoriatic arthritis	0.00114	0.00119	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—psoriatic arthritis	0.00114	0.00118	CcSEcCtD
Melphalan—Rash—Prednisolone—psoriatic arthritis	0.00114	0.00118	CcSEcCtD
Melphalan—Dermatitis—Prednisolone—psoriatic arthritis	0.00114	0.00118	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00114	0.00118	CcSEcCtD
Melphalan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00113	0.00118	CcSEcCtD
Melphalan—Fatigue—Prednisone—psoriatic arthritis	0.00113	0.00117	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0011	0.00114	CcSEcCtD
Melphalan—Infection—Methotrexate—psoriatic arthritis	0.00109	0.00113	CcSEcCtD
Melphalan—Asthenia—Betamethasone—psoriatic arthritis	0.00108	0.00112	CcSEcCtD
Melphalan—Asthenia—Dexamethasone—psoriatic arthritis	0.00108	0.00112	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Melphalan—Nausea—Prednisolone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Melphalan—Pruritus—Dexamethasone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Melphalan—Pruritus—Betamethasone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Melphalan—Vomiting—Triamcinolone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Melphalan—Vomiting—Methylprednisolone—psoriatic arthritis	0.00105	0.00109	CcSEcCtD
Melphalan—Rash—Triamcinolone—psoriatic arthritis	0.00105	0.00109	CcSEcCtD
Melphalan—Dermatitis—Triamcinolone—psoriatic arthritis	0.00105	0.00109	CcSEcCtD
Melphalan—Anorexia—Methotrexate—psoriatic arthritis	0.00105	0.00109	CcSEcCtD
Melphalan—Rash—Methylprednisolone—psoriatic arthritis	0.00104	0.00108	CcSEcCtD
Melphalan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00104	0.00108	CcSEcCtD
Melphalan—Urticaria—Prednisone—psoriatic arthritis	0.00104	0.00108	CcSEcCtD
Melphalan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Melphalan—Diarrhoea—Betamethasone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Melphalan—Hypotension—Methotrexate—psoriatic arthritis	0.00102	0.00106	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000999	0.00104	CcSEcCtD
Melphalan—Nausea—Triamcinolone—psoriatic arthritis	0.000987	0.00102	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—psoriatic arthritis	0.000985	0.00102	CcSEcCtD
Melphalan—Nausea—Methylprednisolone—psoriatic arthritis	0.000984	0.00102	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—psoriatic arthritis	0.000978	0.00102	CcSEcCtD
Melphalan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000967	0.001	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—psoriatic arthritis	0.000966	0.001	CcSEcCtD
Melphalan—Vomiting—Betamethasone—psoriatic arthritis	0.000958	0.000995	CcSEcCtD
Melphalan—Vomiting—Dexamethasone—psoriatic arthritis	0.000958	0.000995	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000954	0.00099	CcSEcCtD
Melphalan—Rash—Betamethasone—psoriatic arthritis	0.00095	0.000987	CcSEcCtD
Melphalan—Rash—Dexamethasone—psoriatic arthritis	0.00095	0.000987	CcSEcCtD
Melphalan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000949	0.000986	CcSEcCtD
Melphalan—Dermatitis—Betamethasone—psoriatic arthritis	0.000949	0.000986	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000947	0.000983	CcSEcCtD
Melphalan—Fatigue—Methotrexate—psoriatic arthritis	0.000946	0.000982	CcSEcCtD
Melphalan—Asthenia—Prednisone—psoriatic arthritis	0.000942	0.000978	CcSEcCtD
Melphalan—Pain—Methotrexate—psoriatic arthritis	0.000938	0.000974	CcSEcCtD
Melphalan—Pruritus—Prednisone—psoriatic arthritis	0.000929	0.000964	CcSEcCtD
Melphalan—Diarrhoea—Prednisone—psoriatic arthritis	0.000898	0.000932	CcSEcCtD
Melphalan—Nausea—Dexamethasone—psoriatic arthritis	0.000895	0.000929	CcSEcCtD
Melphalan—Nausea—Betamethasone—psoriatic arthritis	0.000895	0.000929	CcSEcCtD
Melphalan—Urticaria—Methotrexate—psoriatic arthritis	0.000871	0.000905	CcSEcCtD
Melphalan—Vomiting—Prednisone—psoriatic arthritis	0.000835	0.000866	CcSEcCtD
Melphalan—Rash—Prednisone—psoriatic arthritis	0.000828	0.000859	CcSEcCtD
Melphalan—Dermatitis—Prednisone—psoriatic arthritis	0.000827	0.000858	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000808	0.000839	CcSEcCtD
Melphalan—Asthenia—Methotrexate—psoriatic arthritis	0.000787	0.000817	CcSEcCtD
Melphalan—Nausea—Prednisone—psoriatic arthritis	0.00078	0.000809	CcSEcCtD
Melphalan—Pruritus—Methotrexate—psoriatic arthritis	0.000776	0.000806	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000751	0.000779	CcSEcCtD
Melphalan—Vomiting—Methotrexate—psoriatic arthritis	0.000697	0.000724	CcSEcCtD
Melphalan—Rash—Methotrexate—psoriatic arthritis	0.000692	0.000718	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—psoriatic arthritis	0.000691	0.000717	CcSEcCtD
Melphalan—Nausea—Methotrexate—psoriatic arthritis	0.000652	0.000676	CcSEcCtD
